Literature summary for 3.4.14.5 extracted from

OFarrell, A.M.; van Vliet, A.; Abou Farha, K.; Cherrington, J.M.; Campbell, D.A.; Li, X.; Hanway, D.; Li, J.; Guler, H.P.
Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects (2007), Clin. Ther., 29, 1692-1705.

Search for more literature for 3.4.14.5

Application

Application	Comment	Organism
medicine	pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149, double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects	Homo sapiens

Inhibitors

Inhibitors	Comment	Organism	Structure
PHX1149	pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor, double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)